SRT.F
SRT.F
DE0007165607
SARTORIUS AG I
Loading chart...

Company Profile

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Related stocks

SRT3.DE
SRT3.DE • Germany
SARTORIUS AG V
253 EUR
19.58B USD 1Y +13.7%
STMN.SW
STMN.SW • Switzerland
STRAUMANN N
89.84 CHF
17.26B USD 1Y -2.2%
OBCK.DE
OBCK.DE • Germany
Ottobock SE & Co. KGaA I
53.2 EUR
3.81B USD
AFX.DE
AFX.DE • Germany
Carl Zeiss Meditec AG I
32.42 EUR
3.18B USD 1Y -30.7%
DIM.PA
DIM.PA • France
SARTORIUS STED BIO
212.8 EUR
23.2B USD 1Y +7.8%
1SXP.DE
1SXP.DE • Germany
SCHOTT Pharma AG & Co. KGaA I
23.5 EUR
3.97B USD 1Y +20%
COLO-B.CO
COLO-B.CO • Denmark
Coloplast B A/S
435.9 DKK
14.72B USD 1Y -26.9%
FIE.DE
FIE.DE • Germany
Fielmann Group AG I
37.35 EUR
3.51B USD 1Y -25.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
46.8% p.a.
Max Drawdown (5Y)
-76.2%
Sharpe Ratio (5Y)
-0.45
Beta Factor
1.45
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
🔴 High valuation risk: Avg P/E of 69.2 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (46.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -82.7% in the extended horizon.
ende